Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity

被引:85
作者
Tun-Kyi, Adrian [1 ]
Finn, Greg [1 ]
Greenwood, Alex [2 ]
Nowak, Michael [1 ]
Lee, Tae Ho [1 ]
Asara, John M. [1 ]
Tsokos, George C. [1 ]
Fitzgerald, Kate [3 ]
Israel, Elliot [4 ]
Li, Xiaoxia [5 ]
Exley, Mark [1 ]
Nicholson, Linda K. [2 ]
Lu, Kun Ping [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA
[2] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA
[3] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PATTERN-RECOGNITION RECEPTORS; MURINE CYTOMEGALOVIRUS; INTERLEUKIN-1; RECEPTOR; ADAPTIVE IMMUNITY; ALPHA INDUCTION; VIRAL-INFECTION; DENDRITIC CELLS; RESPONSES; KINASE;
D O I
10.1038/ni.2069
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLRs) shape innate and adaptive immunity to microorganisms. The enzyme IRAK1 transduces signals from TLRs, but mechanisms for its activation and regulation remain unknown. We found here that TLR7 and TLR9 activated the isomerase Pin1, which then bound to IRAK1; this resulted in activation of IRAK1 and facilitated its release from the receptor complex to activate the transcription factor IRF7 and induce type I interferons. Consequently, Pin1-deficient cells and mice failed to mount TLR-mediated, interferon-dependent innate and adaptive immune responses. Given the critical role of aberrant activation of IRAK1 and type I interferons in various immune diseases, controlling IRAK1 activation via inhibition of Pin1 may represent a useful therapeutic approach.
引用
收藏
页码:733 / U142
页数:10
相关论文
共 50 条
  • [31] Type I interferon promotes the fate of Toll-like receptor 9-stimulated follicular B cells to plasma cell differentiation
    Higuchi, Ryota
    Tanaka, Kaori
    Saito, Yuichi
    Murakami, Daisuke
    Nakagawa, Takashi
    Nutt, Stephen L.
    Ohkawa, Yasuyuki
    Baba, Yoshihiro
    PNAS NEXUS, 2024, 3 (04):
  • [32] Baculovirus Induces Type I Interferon Production through Toll-Like Receptor-Dependent and -Independent Pathways in a Cell-Type-Specific Manner
    Abe, Takayuki
    Kaname, Yuuki
    Wen, Xiaoyu
    Tani, Hideki
    Moriishi, Kohji
    Uematsu, Satoshi
    Takeuchi, Osamu
    Ishii, Ken J.
    Kawai, Taro
    Akira, Shizuo
    Matsuura, Yoshiharu
    JOURNAL OF VIROLOGY, 2009, 83 (15) : 7629 - 7640
  • [33] Role of macrophage-mediated Toll-like receptor 4-interleukin-1R signaling in ectopic tongue pain associated with tooth pulp inflammation
    Kanno, Kohei
    Shimizu, Kohei
    Shinoda, Masamichi
    Hayashi, Makoto
    Takeichi, Osamu
    Iwata, Koichi
    JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [34] Neu1 Sialidase and Matrix Metalloproteinase-9 Cross-talk Is Essential for Toll-like Receptor Activation and Cellular Signaling
    Abdulkhalek, Samar
    Amith, Schammim Ray
    Franchuk, Susan L.
    Jayanth, Preethi
    Guo, Merry
    Finlay, Trisha
    Gilmour, Alanna
    Guzzo, Christina
    Gee, Katrina
    Beyaert, Rudi
    Szewczuk, Myron R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (42) : 36532 - 36549
  • [35] Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism
    Niu, Congrong
    Li, Li
    Daffis, Stephane
    Lucifora, Julie
    Bonnin, Marc
    Maadadi, Sarah
    Salas, Eduardo
    Chu, Ruth
    Ramos, Hilario
    Livingston, Christine M.
    Beran, Rudolf K.
    Garg, Abhishek V.
    Balsitis, Scott
    Durantel, David
    Zoulim, Fabien
    Delaney, William E.
    Fletcher, Simon P.
    JOURNAL OF HEPATOLOGY, 2018, 68 (05) : 922 - 931
  • [36] Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum Coronarium L.
    Tanaka, Sachi
    Koizumi, Shin-ichi
    Masuko, Kazutaka
    Makiuchi, Naoko
    Aoyagi, Yuka
    Quivy, Emi
    Mitamura, Rieko
    Kano, Tsutomu
    Ohkuri, Takayuki
    Wakita, Daiko
    Chamoto, Kenji
    Kitamura, Hidemitsu
    Nishimura, Takashi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (02) : 226 - 232
  • [37] Toll-like receptor 9 ligands increase type I interferon induced B-cell activating factor expression in chronic rhinosinusitis with nasal polyposis
    Xu, Jun
    Lee, Jin-Woo
    Park, Soo-Kyoung
    Lee, Sung-Bok
    Yoon, Young-Hoon
    Yeon, Sun-Hee
    Rha, Ki-Sang
    Choi, Ji-Ae
    Song, Chang-Hwa
    Kim, Yong Min
    CLINICAL IMMUNOLOGY, 2018, 197 : 19 - 26
  • [38] Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir
    Georgel, Anne-France
    Cayet, Delphine
    Pizzorno, Andres
    Rosa-Calatrava, Manuel
    Paget, Christophe
    Sencio, Valentin
    Dubuisson, Jean
    Trottein, Francois
    Sirard, Jean-Claude
    Carnoy, Christophe
    ANTIVIRAL RESEARCH, 2019, 168 : 28 - 35
  • [39] Isoliquiritigenin Suppresses the Toll-Interleukin-1 Receptor Domain-Containing Adapter Inducing Interferon-β (TRIF)-Dependent Signaling Pathway of Toll-Like Receptors by Targeting TBK1
    Park, Se-Jeong
    Youn, Hyung-Sun
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2010, 58 (08) : 4701 - 4705
  • [40] Protein phosphatase PP1 negatively regulates the Toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage
    Gu, Meidi
    Zhang, Ting
    Lin, Wenlong
    Liu, Zhiyong
    Lai, Rongrong
    Xia, Dajing
    Huang, He
    Wang, Xiaojian
    CELLULAR SIGNALLING, 2014, 26 (12) : 2930 - 2939